SB-235699
Code | Size | Price |
---|
TAR-T28684-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28684-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28684-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
SB-235699, a p38 MAPK inhibitor, is used potentially for the treatment of psoriasis.
CAS:
180869-32-3
Formula:
C19H19FN4
Molecular Weight:
322.387
Purity:
0.98
SMILES:
Fc1ccc(cc1)-c1ncn(C2CCNCC2)c1-c1ccncc1
References
1. Murakami M, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Wada H, Umeshita K, Kennichi W, Doki Y, Mori M, Nagano H. Isolated metastasis to the gallbladder from hepatocellular carcinoma. Hepatol Res. 2010 Aug;40(8):793-8. doi: 10.1111/j.1872-034X.2010.00689.x. PubMed PMID: 20649819.